The herpes simplex virus 1 and 2 (HSV-1 and HSV-2) particles consist of four concentric structural elements, i.e., a central DNA core; a capsid consisting of the products of the genes U L 18 (VP23), U L 19 (VP5), U L 26 (VP21, VP22a, and VP24), U L 35 (VP26), and U L 38 (VP19c); an amorphous protein structure called the tegument, which surrounds the capsid; and an envelope containing viral glycoproteins (4, 6, 8, 14, 21, 22, 30, 34, 36) . The HSV genomes are both transcribed and replicated in the nucleus, which is also the site of immature viral capsid assembly. The studies described in this report were initiated following the observation that the product of a newly discovered open reading frame designated U L 43.5 and mapping antisense to U L 43 colocalized with capsid proteins in dense structures located at the periphery of the nucleus late in infection (44) . Spurred by these observations, we began a systematic study of the localization of several classes of structural and nonstructural viral proteins involved in the various stages of mature capsid assembly.
Viral DNA is synthesized via a rolling-circle mechanism (reviewed in reference 36) in a central nuclear compartment that has been defined by the presence of the single-stranded viral DNA-binding protein ICP8 (9) . The newly replicated DNA is cleaved from its concatemeric form and packaged into the preformed, immature capsids, which then acquire an envelope derived from the inner nuclear membrane upon exit from the nucleus. In this report, we compare the distribution of capsid proteins with both ICP8 and the viral DNA polymerase accessory protein encoded by the U L 42 gene, as well as the U L 15 gene product, which has been associated with cleavage and packaging of viral DNA on the basis of analyses of a spontaneously arising mutant virus carrying a temperaturesensitive (ts) mutation in the U L 15 gene. At the nonpermissive temperature, cells infected with this mutant accumulate uncleaved concatemeric viral DNA, and packaging into preformed capsids does not ensue (1, 26) . Several other viruses which contain ts mutations in genes whose products are either capsid proteins or proteins known to be required for viral DNA synthesis accumulate uncleaved viral DNA (36) .
Previously, we observed that ICP35 protein was distributed in discrete patches at the periphery of the nucleus late in infection (44) . We asked whether these discrete patches also contained proteins associated with mature capsids, thereby suggesting that these sites could be sites of capsid assembly rather than represent a concentration of soluble proteins. We therefore compared the distribution of ICP35 with that of ICP5 and U L 38 (VP19c). Relevant to this are the following points. (i) The U L 26 gene encodes a protease precursor, Pra (19) . A transcriptional unit designated U L 26.5, 3Ј coterminal with the U L 26 gene, yields ICP35cd (18) . Both the protease precursor Pra and the ICP35cd protein are cleaved by the protease to yield several sets of products. ICP35cd is cleaved to yield ICP35ef and a small carboxy-terminal peptide (19) . Pra is cleaved to yield the mature protease, a polypeptide designated ICP35ab, and the same small carboxy-terminal peptide as that cleaved from ICP35cd (10, 12, 20) . ICP35ab, ICP35ef, and Prn (the amino-terminal cleavage product of Pra) form the scaffolding of the capsid. Upon packaging of viral DNA, only Prn (VP21) remains in the capsid (14, 25) . Monoclonal antibody H725 reacts with an epitope present in Pra, ICP35ab, ICP35cd, and ICP35ef but not in Prn (3, 4, 18) . This antibody therefore identifies accumulations of U L 26 gene products either dispersed or contained in immature capsids. (ii) In contrast, ICP5, the major capsid protein, is a component of both immature and mature capsids, and antibody to ICP5 identifies the accumulation of soluble protein as well as the accumulation of both immature and mature capsids (36) . (iii) The U L 38 gene encodes a capsid protein designated VP19c (5, 16, 21) . This protein has been previously shown to bind viral DNA in a nonspecific fashion and may play a role in anchoring the DNA to the capsid (5, 45) .
The site of acquisition of the tegument is uncertain. The observations that purified capsids from nuclei do not contain tegument proteins (14) and that thickened patches of membrane form at the site of envelopment at the inner nuclear membrane have led to the suggestion that tegument proteins are part of the envelopment complex at the nuclear membrane (35) . The localization of two tegument proteins has been investigated in this study. The product of the U S 11 gene is an abundant tegument protein, which binds RNA in a sequenceand conformation-specific fashion, binds to ribosomes, and also localizes in the nucleus (11, (37) (38) (39) . The alpha-trans-inducing factor (␣TIF) (24, 43) , also known as virion protein 16 (42) , transactivates the transcription of the ␣ genes-the first set of genes expressed in productively infected cells (28, 36) . ␣TIF is also an essential tegument protein. Virions produced in cells infected with ts mutant viruses generated by substitution of cysteines in the ␣TIF protein for glycines fail to mature at the nonpermissive temperature (27) .
In this report we show the following. (i) Viral proteins involved in the synthesis of viral DNA are dispersed throughout a large portion of the nucleus. (ii) The proteins associated with immature capsids, i.e., ICP5, ICP35, and U L 38 (VP19c), aggregate in defined, antigenically dense nuclear structures frequently located at the edges of the large, diffuse nuclear domains defined by the proteins involved in DNA synthesis. (iii) The U L 15 protein, which is known to be required for packaging of viral DNA into capsids but is not itself a capsid protein, localizes with proteins associated with viral DNA synthesis and surprisingly not with the aggregates of capsid proteins. We conclude from studies presented here that late in infection at the time of heightened assembly of virions, components of the capsid and some tegument proteins assemble in discrete nuclear structures on the fringes of the space occupied by proteins involved in DNA synthesis. We have designated these structures assemblons to show that they include proteins of both mature and immature capsids and also some tegument proteins.
MATERIALS AND METHODS
Cells and viruses. HSV-1 strain F [HSV-1(F)] is the prototype strain used in our laboratories (13) . HSV-1(F)R7032 lacks the entire U S 8 gene which encodes glycoprotein E (23); it was used in immunofluorescence studies to avoid nonspecific immunofluorescence caused by binding of immunoglobulin G (IgG) to the Fc receptor expressed by glycoprotein E. HSV-1(F)R2063 carries two ts mutations in the U L 48 (␣TIF) gene, and its ts lesion in the ␣4 gene is repaired (27) . HSV-1(mP)ts66-4 carries a ts mutation in the U L 15 gene (26) . At the nonpermissive temperatures, viral DNA is synthesized but remains in concatemers and is not packaged into preformed capsids (1, 26) . All experiments were done in Vero cells grown in Dulbecco's modified Eagle's medium supplemented with 5% newborn calf serum.
Antibodies. Rabbit polyclonal antibodies to the U L 10 (glycoprotein M) (2), U L 15 (1) , and U L 43.5 (44) proteins have been described previously. Rabbit polyclonal antibody to the capsid protein U L 38 was generated by immunization of rabbits with a bacterial fusion protein as described below. The preparation of the monoclonal antibody to U S 11 protein has been described elsewhere (39) . Fig. 1, line 4) , was predicted to encode the bacterial GST in frame with the amino-terminal region of U L 38. pRB4955 was digested with pPuMI and EcoRI (the EcoRI site is in the vector polylinker), and the ends were made blunt with mung bean nuclease (New England Biolabs, Beverly, Mass.) and religated. The resultant plasmid, designated pRB4956, contains the sequence encoding the amino-terminal 54 amino acids of U L 38 fused to the GST gene ( Fig. 1, line 5 ). DNA encoding the junction between GST and U L 38 was sequenced to verify that the two open ORFs were maintained (data not shown). Production of the fusion protein was induced by the addition of IPTG (isopropyl-␤-D-thiogalactopyranoside) to the medium with Escherichia coli BL21 cells transformed with pRB4956, followed by affinity purification with glutathione cross-linked to agarose beads (Sigma), and checked for purity by separation on polyacrylamide gels followed by staining with Coomassie brilliant blue. New Zealand White rabbits were immunized with the affinity-purified protein as previously described (2) . Samples of preimmune and immune serum were collected and analyzed for reactivity to U L 38 protein by immunoblotting.
Polyacrylamide gel electrophoresis and immunoblotting. Infected cell lysates were separated in denaturing gels consisting of 10% polyacrylamide and 0.2% sodium dodecyl sulfate, and the proteins were electrically transferred to nitrocellulose sheets. The sheets were soaked at room temperature for 1 h in phosphate-buffered saline (PBS) containing 5% skim milk (Carnation) and then reacted at room temperature for 1 h with the U L 38 polyclonal antiserum (1:1,000 dilution) or with preimmune serum (1:500 dilution) in PBS containing 1% bovine serum albumin (BSA). The blots were washed three times for 5 min in PBS containing 5% milk and then reacted at room temperature for 1 h with a 1:3,000 dilution of goat anti-rabbit antibody conjugated to alkaline phosphatase. The blots were washed for 10 min in PBS containing 5% milk and then four times for 10 min in PBS; they were then developed by using reagents and protocols supplied in a kit from the manufacturer (Bio-Rad Laboratories, Richmond, Calif.).
Immunofluorescence. Approximately 5 ϫ 10 4 Vero cells were seeded onto glass slides (Cell-line Inc., Nawfield, N.J.), allowed to attach overnight, and then exposed to 10 PFU of virus per cell. After 16 to 18 h of incubation at temperatures stated in Results, the cells were fixed in ice-cold methanol, air dried, and reacted with PBS plus either 1% BSA or a mixture of 1% BSA and 20% normal human plasma for 1 h at room temperature to block nonspecific reactivity of the antibodies. The cells were then reacted for 2 h at room temperature with primary antibody diluted in PBS supplemented with 1% BSA alone or along with 10% normal human plasma, rinsed extensively with PBS, reacted for 1 h with the appropriate secondary antibody, rinsed extensively, and mounted in 95% glycerol in PBS containing 1 mg of p-phenylenediamine per ml to reduce fading of the FITC signal. The slides were examined in a Zeiss confocal fluorescence microscope; digitized images of the fluorescent-antibody-stained cells were acquired with software provided with the confocal microscope and printed by a CP210 Codonics printer. Single-color images were acquired by excitation with an argon/ krypton laser at 488 nm (FITC) or 568 nm (Texas red). Double-stained images were obtained by acquiring a split image of both fluorochromes filtered by 515-540-nm band-pass (FITC) and 590-nm long-pass (Texas red) filters and subsequent overlaying of the two color images.
RESULTS
Specificity of the U L 38 rabbit polyclonal antiserum. We generated a rabbit polyclonal antiserum to U L 38 protein for use in colocalization studies with mouse monoclonal antibodies to ICP5 and ICP35. The antibody produced following inoculation of rabbits with U L 38-GST fusion protein specifically reacted with a protein of approximately 53 kDa present in HSV-1(F)-infected cell lysates (Fig. 2, right panel) . The antibody did not react with any proteins present in mock-infected cell lysates (right panel), nor did the preimmune sera react with any proteins present in either uninfected or infected cell lysates (left panel).
Redistribution of ICP35 and ICP5 during HSV-1 infection. The localization of two proteins associated with immature (ICP35) and mature (ICP5) capsids (33, 36) was examined at early (6 h) and late (16 h) times postinfection. At 6 h postinfection, both ICP5 (Fig. 3A) and ICP35 (Fig. 3D) proteins are diffusely distributed in an irregular pattern throughout the nucleus. In some cells, some aggregation of capsid proteins can be seen (Fig. 3A, compare cells labeled a and b) , which progresses to form discrete, brightly fluorescent structures by 16 h postinfection (Fig. 3B [ICP5] , cell labeled a; Fig. 3C  [ICP5] ; Fig. 3E and F [ICP35] ). The localization of the tegument protein, ␣TIF (Fig. 3G to I) , is discussed below.
Colocalization of U L 38, ICP35a-f, and ICP5. As previously reported (44) , the U L 43.5 protein colocalizes with ICP35 in dense, strongly fluorescent nuclear structures (Fig. 4a to c) . In this series of experiments, we asked whether these structures contained exclusively proteins associated with immature capsids by comparing the localization of three proteins associated with mature (ICP5 and U L 38) and immature (ICP5, U L 38, and ICP35) capsids. The U L 38 protein was detected with FITCconjugated antibody against rabbit IgG. ICP5 and ICP35 were detected with Texas red-conjugated antibody against mouse IgG. The results of these studies show that in some cells, ICP35 and ICP5 (Fig. 4g , j, and m) aggregated in both diffuse and highly dense, strongly fluorescent nuclear structures. Colocalization of these proteins with the U L 38 protein is visualized by yellow fluorescence (Fig. 4 , right-hand column). U L 38 protein colocalized both with ICP35 and ICP5 in the dense, strongly fluorescent nuclear structures (Fig. 4k, l , n, o, q, and r) and with the diffuse, less strongly fluorescent ICP5 (Fig. 4n and o) but not with the diffusely distributed ICP35 (Fig. 4h and i) . In  Fig. 4 , we have illustrated the dominant pattern consisting of a small number of dense structures (three to eight) prevalent in the infected-cell nuclei late in infection. In some cells, particularly in those in which infection was retarded, the nuclei contained a large number of relatively smaller dense, fluorescent structures. This is illustrated in Fig. 5b and c. To define the localization of these dense structures more precisely, infected cells were reacted simultaneously with rabbit polyclonal antibody to glycoprotein M and with monoclonal antibody to ICP35. As illustrated in Fig. 6g to i, the dense, strongly fluorescent nuclear structures containing ICP35 were separated from the uniform shell formed by glycoprotein M in the nuclear membrane.
Tegument proteins partially overlap the dense, strongly fluorescent nuclear structures containing capsid proteins. We have examined the localization of two tegument proteins, U S 11 and ␣TIF. U S 11 protein accumulated in diffuse nuclear regions at or near nuclear membranes in most of the infected cells, in addition to nucleoli as previously reported (39) . Even in cells in which U L 38 protein is largely in the dense, strongly fluorescent nuclear structures, the U S 11 protein overlapped only in part with these structures containing capsid proteins (Fig. 4d to f) .
The localization of ␣TIF was examined under five conditions, i.e., in cells infected with HSV-1(F) or with viruses carrying ts mutations in U L 15 [HSV-1(mP)ts66-4] or in ␣TIF (R2603) and maintained at either permissive or nonpermissive temperatures. The results of these studies were as follows. (i) Abrogation of DNA cleavage and packaging did not affect the appearance of any of the compartments defined by the presence of capsid proteins or proteins associated with DNA synthesis in cells infected with this mutant virus at the nonpermissive temperature. (ii) As a general rule, ␣TIF was an abundant nuclear protein that was present either diffusely throughout the nucleus (Fig. 5a ) with accumulation of protein in nuclear membranes ( Fig. 3G and H) or aggregated and only partially filling the nucleus (Fig. 3I) . The compartment occupied by ␣TIF was considerably more diffuse and only partially colocal- ized with U L 38 protein and, by extension, with other capsid proteins (Fig. 5a to c) . (iii) At the nonpermissive temperature for the U L 15 mutant protein, the dominant features of the infected cells were that both aggregates of ␣TIF localized within the nucleus and that ␣TIF accumulated at the margins of the nucleus in the proximity of the nuclear membranes (Fig.  5d) . In this instance, there was little or no overlap in the localization of ␣TIF and the dense, fluorescent nuclear structures containing U L 38 protein and, by extension (as indicated below), other capsid proteins (Fig. 5f) . We found no change in distribution of capsid or tegument proteins in cells infected with R2603 (␣TIF ts mutant) at the nonpermissive temperature (data not shown).
The localization of capsid proteins differs from that of proteins associated with viral DNA synthesis. Viral proteins associated with DNA replication accumulate in a specific nuclear compartment that is defined by the presence of the viral singlestranded-DNA-binding protein ICP8 (9) . We examined the distribution of another protein associated with viral DNA synthesis, the polymerase accessory protein encoded by U L 42. Our observations, supported by other colocalization studies described below, are that the viral DNA replication compartment abuts but does not overlap the dense nuclear fluorescent structures containing capsid proteins (Fig. 6a to c) . Studies with monoclonal antibody to ICP8 yielded similar results (not shown).
Colocalization of U L 15 protein with proteins involved in viral DNA synthesis. Earlier studies have shown that U L 15 protein is redistributed from the cytoplasm to the nucleus between 6 and 12 h after infection (1) . In this study, the Fig. 6e ; HSV-1(mP)ts66-4 at 37ЊC, Fig. 5k) ]. In the other pattern, the distribution of U L 15 protein appears to be more diffuse (e.g., Fig.  5h ). In cells in which ICP5 did not localize to the discrete peripheral structures but accumulated in large amounts, filling the nucleus, its distribution overlapped the distribution of the U L 15 protein (Fig. 5j to l) . The more common image is that of localization of the dense nuclear fluorescent structures containing capsid proteins at the periphery and only partially overlapping the compartment containing the U L 15 protein (e.g., Fig. 5g to i and Fig. 6d to f) . The most striking and unexpected observation was that U L 15 protein colocalized with the proteins associated with viral DNA synthesis (e.g., U L 42 [ Fig. 6j to l]).
DISCUSSION
In a recent paper, we reported that the product of U L 43.5, a newly discovered open reading frame, colocalizes with the capsid protein ICP35 (Fig. 4a to c) in nuclear compartments which we have described as dense fluorescent nuclear structures (44) . A central and intriguing question was whether this association was unique to the proteins tested or, rather, reflected a nuclear compartmentalization of the various functions associated with viral morphogenesis: DNA synthesis, capsid assembly, packaging of DNA, and envelopment. To investigate the possibility that a functional compartmentalization exists, we prepared antibody to one additional capsid protein, VP19C (15, 42) , encoded by U L 38 (5, 21) . We then analyzed the localization of three capsid proteins (ICP35, ICP5, and U L 38), two tegument proteins (U S 11 and ␣TIF), proteins involved in viral DNA synthesis (ICP8 [results not shown] and the product of the U L 42 gene) and packaging (U L 15 [1, 26] ), and a component of the virion envelope glycoprotein M, the product of the U L 10 gene (2). We also asked whether this compartmentalization occurred in the absence of certain viral functions, i.e., DNA packaging and virion maturation, by examining cells infected with mutant viruses carrying ts mutations in either the U L 15 (Fig. 5) or the ␣TIF (data not shown) genes and maintained at nonpermissive temperatures.
We have identified compartments of proteins in which three distinct functions involved in viral assembly appear to occur. These compartments contain capsid proteins, proteins involved in DNA synthesis, and tegument proteins. We have recently shown that after the onset of DNA synthesis, ICP4 aggregates into dense structures (17) , which form a compartment different from those described here. The salient features of our studies which merit discussion are as follows. (i) The capsid compartment is defined by the coalescence of ICP5, ICP35, and VP19c (U L 38) into the dense nuclear structures, which occurs late in infection in most cells. These structures were located at the periphery of the nucleus separate from nuclear membranes and did not significantly overlap the compartments containing proteins involved in viral DNA synthesis.
(ii) U L 15 protein, generally associated with viral DNA cleavage and packaging, colocalized with the DNA polymerase accessory protein U L 42 and ICP8 (not shown) but not with the dense nuclear bodies containing capsid proteins. (iii) The predominant distribution of the tegument proteins ␣TIF and U S 11 was in asymmetrically arranged masses near the periphery of the nucleus, adjacent to or partially overlapping with the dense nuclear structures containing capsid proteins, although the distribution of the two proteins varied somewhat from cell to cell. We did not observe significant differences in the compartmentalization of the proteins studied here in cells in which either DNA packaging was abrogated (U L 15 ts mutant) or virions did not mature (␣TIF mutant).
The hypothesis that the dense, strongly fluorescent structures contain both protein forming immature capsids and the immature capsids themselves, in addition to any mature capsids which may also be present, is supported by two observations: (i) the presence of large amounts of ICP35 protein within these structures and (ii) the formation of these structures in infected cells under conditions in which immature capsids (lacking viral DNA) are made, viral DNA accumulates in the form of concatemers, but the DNA is not cleaved from concatemers and packaged into the preformed capsids (1, 26) . At the time points investigated in this report, infectious virus accumulates exponentially, and we assume that this represents the time of maximum assembly of capsids. "Dense fluorescent nuclear structures," albeit descriptive, is an unsatisfactory term for these structures, and we propose to designate them assemblons, i.e., bodies in which proteins involved in capsid assembly aggregate and most probably assemble.
The arrangement of assemblons in the periphery of the nucleus surrounding and abutting the compartment containing the proteins involved in viral DNA synthesis suggests the existence of a machinery which feeds upon (i.e., captures, packages, and cleaves) viral DNA generated within the DNA synthesis compartment. The distribution of U L 15 protein raises some interesting issues. U L 15 bears partial homology to the bacteriophage terminase involved in cleavage and packaging of phage DNA (7, 29, 32) , and analyses of a ts mutant virus revealed the requirement for functional U L 15 protein for cleavage and packaging of HSV-1 DNA into capsids (1, 26) . Because it is generally thought that cleavage of newly synthesized viral DNA occurs concurrently with its packaging (reviewed in reference 36), it could have been predicted that U L 15 would colocalize with immature capsids or with structures associated with capsid assembly. Thus, the colocalization of U L 15 protein with proteins involved in viral DNA synthesis and, conversely, the virtually complete exclusion of U L 15 protein from the assemblons were unexpected. Our results suggest that U L 15 becomes associated with DNA-protein complexes prior to packaging and that it may even be an accessory component of the machinery which synthesizes viral DNA.
In contrast, and with few exceptions, the two tegument proteins investigated in this study (e.g., Fig. 5d to f) were localized closer to nuclear membranes than were the assemblons. We have not resolved the question of whether tegument proteins bind to capsids during capsid assembly or at the time of envelopment. Both U S 11 and ␣TIF are abundant virion proteins; however, our results suggest that the assemblons do not contain large amounts of U S 11 or ␣TIF as might be expected if tegument proteins bound to capsids within these structures.
The conclusions drawn from these studies have generated a number of questions. In principle, we could have expected that assembly of capsids in the nucleus would occur at random but that the capsids would move radially to the nuclear membrane. The fact that the capsid proteins accumulate in assemblons suggests that assembly is facilitated by and is dependent on protein concentration. This raises the question of the mechanisms which result both in the coalescence of the capsid proteins into assemblons and in the segregation of proteins involved in DNA synthesis and those forming the tegument.
An additional, equally intriguing question concerns the relationship between the various viral compartments and the electron-dense bodies which are readily apparent upon electron-microscopic examination of thin sections of infected cells (31, 40) . Progress in identification of the components of these bodies will require the development of methods which enable penetration of antibodies into cells without distortion of the nuclear architecture.
